Kereiakes, Dean J <br/><br/>
Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials.  [electronic resource] 

 -  JACC. Cardiovascular interventions  Dec 2010 
 - 1229-39 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1876-7605 
<br/><br/><label>Standard No.: </label>10.1016/j.jcin.2010.09.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angioplasty, Balloon, Coronary<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Coronary Artery Bypass<br/>Coronary Artery Disease--drug therapy<br/>Drug-Eluting Stents<br/>Everolimus<br/>Female<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Paclitaxel--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Sirolimus--administration & dosage<br/>Time Factors<br/>United States